(1->4)-beta-D-glucan multiple interactions ISO Prkar2a (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PRKAR2A mRNA CTD PMID:36331819 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO PRKAR2A (Homo sapiens) 6480464 o and p'-DDT results in increased expression of PRKAR2A mRNA CTD PMID:19371625 1,2-dichloroethane increases expression ISO Prkar2a (Mus musculus) 6480464 ethylene dichloride results in increased expression of PRKAR2A mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO Prkar2a (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of PRKAR2A mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PRKAR2A mRNA CTD PMID:29097150 17beta-estradiol increases expression ISO PRKAR2A (Homo sapiens) 6480464 Estradiol results in increased expression of PRKAR2A mRNA CTD PMID:23019147 and PMID:31614463 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PRKAR2A mRNA CTD PMID:32145629 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKAR2A mRNA CTD PMID:33387578 2-ethoxyethanol increases expression EXP 6480464 2-ethoxyethanol results in increased expression of PRKAR2A mRNA CTD PMID:19643169 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of PRKAR2A mRNA CTD PMID:19643169 3',5'-cyclic AMP multiple interactions EXP 6480464 Clozapine inhibits the reaction [Cyclic AMP binds to PRKAR2A protein] and Haloperidol promotes the reaction [Cyclic AMP binds to PRKAR2A protein] CTD PMID:11907174 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:32119087 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin analog results in decreased expression of PRKAR2A protein CTD PMID:26072098 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1 and 2-dithiol-3-thione results in increased expression of PRKAR2A mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression ISO PRKAR2A (Homo sapiens) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PRKAR2A protein CTD PMID:34186270 4-vinylcyclohexene dioxide affects expression ISO Prkar2a (Mus musculus) 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of PRKAR2A mRNA CTD PMID:20829426 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PRKAR2A mRNA CTD PMID:22504374 acrolein multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRKAR2A mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PRKAR2A mRNA CTD PMID:32699268 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of PRKAR2A mRNA CTD PMID:28959563 all-trans-retinoic acid decreases expression ISO PRKAR2A (Homo sapiens) 6480464 Tretinoin results in decreased expression of PRKAR2A mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRKAR2A mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PRKAR2A mRNA CTD PMID:32699268 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of PRKAR2A mRNA CTD PMID:30779732 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of PRKAR2A mRNA and Amphetamine results in increased expression of PRKAR2A protein CTD PMID:16896163 amphetamine affects response to substance EXP 6480464 PRKAR2A protein affects the susceptibility to Amphetamine CTD PMID:16896163 arsane decreases expression ISO Prkar2a (Mus musculus) 6480464 Arsenic results in decreased expression of PRKAR2A mRNA CTD PMID:19654921 arsenic atom decreases expression ISO Prkar2a (Mus musculus) 6480464 Arsenic results in decreased expression of PRKAR2A mRNA CTD PMID:19654921 benzatropine multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of PRKAR2A protein CTD PMID:34122009 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of PRKAR2A mRNA CTD PMID:21839799 benzo[a]pyrene increases methylation ISO PRKAR2A (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of PRKAR2A promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO PRKAR2A (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of PRKAR2A 3' UTR CTD PMID:27901495 bis(2-chloroethyl) sulfide increases phosphorylation ISO PRKAR2A (Homo sapiens) 6480464 Mustard Gas results in increased phosphorylation of PRKAR2A protein CTD PMID:19845377 bisphenol A increases expression ISO PRKAR2A (Homo sapiens) 6480464 bisphenol A results in increased expression of PRKAR2A mRNA CTD PMID:19371625 bisphenol A decreases expression ISO PRKAR2A (Homo sapiens) 6480464 bisphenol A results in decreased expression of PRKAR2A protein CTD PMID:31675489 and PMID:34186270 bisphenol A decreases expression ISO Prkar2a (Mus musculus) 6480464 bisphenol A results in decreased expression of PRKAR2A mRNA CTD PMID:33221593 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PRKAR2A mRNA CTD PMID:32145629 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PRKAR2A mRNA CTD PMID:29097150 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PRKAR2A mRNA CTD PMID:25181051 Bisphenol B increases expression ISO PRKAR2A (Homo sapiens) 6480464 bisphenol B results in increased expression of PRKAR2A protein CTD PMID:34186270 bisphenol F increases expression ISO PRKAR2A (Homo sapiens) 6480464 bisphenol F results in increased expression of PRKAR2A protein CTD PMID:34186270 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of PRKAR2A mRNA CTD PMID:19167457 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of PRKAR2A mRNA CTD PMID:25993096 caffeine decreases phosphorylation ISO PRKAR2A (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of PRKAR2A protein CTD PMID:35688186 cannabidiol multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of PRKAR2A protein CTD PMID:34122009 carbon nanotube increases expression ISO Prkar2a (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 choline multiple interactions ISO Prkar2a (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRKAR2A gene CTD PMID:20938992 clozapine multiple interactions EXP 6480464 Clozapine inhibits the reaction [Cyclic AMP binds to PRKAR2A protein] CTD PMID:11907174 clozapine multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 [Cuprizone co-treated with Clozapine] results in decreased expression of PRKAR2A protein CTD PMID:34122009 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of PRKAR2A mRNA and Clozapine results in decreased expression of PRKAR2A protein CTD PMID:11907174 cobalt dichloride decreases expression ISO PRKAR2A (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of PRKAR2A mRNA CTD PMID:19320972 colforsin daropate hydrochloride increases phosphorylation ISO PRKAR2A (Homo sapiens) 6480464 Colforsin results in increased phosphorylation of PRKAR2A protein CTD PMID:25943029 Cuprizon multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of PRKAR2A protein more ... CTD PMID:34122009 deoxynivalenol increases phosphorylation ISO Prkar2a (Mus musculus) 6480464 deoxynivalenol results in increased phosphorylation of PRKAR2A protein CTD PMID:23352502 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of PRKAR2A mRNA CTD PMID:17452286 dibutyl phthalate increases expression ISO Prkar2a (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of PRKAR2A mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKAR2A mRNA CTD PMID:27188386 doxorubicin affects expression ISO PRKAR2A (Homo sapiens) 6480464 Doxorubicin affects the expression of PRKAR2A protein CTD PMID:29385562 enzyme inhibitor multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PRKAR2A protein CTD PMID:23301498 ethanol affects splicing ISO Prkar2a (Mus musculus) 6480464 Ethanol affects the splicing of PRKAR2A mRNA CTD PMID:30319688 folic acid multiple interactions ISO Prkar2a (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRKAR2A gene CTD PMID:20938992 genistein increases expression ISO PRKAR2A (Homo sapiens) 6480464 Genistein results in increased expression of PRKAR2A mRNA CTD PMID:19371625 haloperidol multiple interactions EXP 6480464 Haloperidol promotes the reaction [Cyclic AMP binds to PRKAR2A protein] CTD PMID:11907174 haloperidol multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 [Cuprizone co-treated with Haloperidol] results in decreased expression of PRKAR2A protein CTD PMID:34122009 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of PRKAR2A mRNA and Haloperidol results in increased expression of PRKAR2A protein CTD PMID:11907174 ivermectin decreases expression ISO PRKAR2A (Homo sapiens) 6480464 Ivermectin results in decreased expression of PRKAR2A protein CTD PMID:32959892 L-methionine multiple interactions ISO Prkar2a (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRKAR2A gene CTD PMID:20938992 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of PRKAR2A mRNA CTD PMID:30467583 methimazole increases expression EXP 6480464 Methimazole results in increased expression of PRKAR2A mRNA CTD PMID:22504374 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of PRKAR2A gene CTD PMID:23303685 monocrotaline increases expression ISO Prkar2a (Mus musculus) 6480464 Monocrotaline results in increased expression of PRKAR2A mRNA CTD PMID:28818515 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [resveratrol results in increased phosphorylation of PRKAR2A protein] CTD PMID:25943029 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide decreases phosphorylation ISO PRKAR2A (Homo sapiens) 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased phosphorylation of PRKAR2A protein CTD PMID:25943029 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PRKAR2A mRNA CTD PMID:20360939 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of PRKAR2A mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PRKAR2A mRNA CTD PMID:25729387 ozone multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRKAR2A mRNA more ... CTD PMID:32699268 paracetamol decreases expression ISO PRKAR2A (Homo sapiens) 6480464 Acetaminophen results in decreased expression of PRKAR2A mRNA CTD PMID:21420995 perfluorooctane-1-sulfonic acid multiple interactions ISO Prkar2a (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PRKAR2A mRNA CTD PMID:36331819 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PRKAR2A mRNA CTD PMID:20360939 phenylpropanolamine increases expression EXP 6480464 Phenylpropanolamine results in increased expression of PRKAR2A mRNA and Phenylpropanolamine results in increased expression of PRKAR2A protein CTD PMID:17684035 pirinixic acid decreases expression ISO Prkar2a (Mus musculus) 6480464 pirinixic acid results in decreased expression of PRKAR2A mRNA CTD PMID:17426115 potassium dichromate increases expression ISO Prkar2a (Mus musculus) 6480464 Potassium Dichromate results in increased expression of PRKAR2A mRNA CTD PMID:23608068 quercetin multiple interactions ISO Prkar2a (Mus musculus) 6480464 Quercetin inhibits the reaction [POMC protein results in increased phosphorylation of PRKAR2A protein] CTD PMID:21290442 resveratrol increases expression ISO PRKAR2A (Homo sapiens) 6480464 resveratrol results in increased expression of PRKAR2A mRNA CTD PMID:19371625 resveratrol multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [resveratrol results in increased phosphorylation of PRKAR2A protein] CTD PMID:25943029 resveratrol increases phosphorylation ISO PRKAR2A (Homo sapiens) 6480464 resveratrol results in increased phosphorylation of PRKAR2A protein CTD PMID:25943029 resveratrol increases phosphorylation ISO Prkar2a (Mus musculus) 6480464 resveratrol results in increased phosphorylation of PRKAR2A protein CTD PMID:25943029 SB 431542 multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKAR2A mRNA CTD PMID:27188386 sodium arsenite increases expression ISO PRKAR2A (Homo sapiens) 6480464 sodium arsenite results in increased expression of PRKAR2A mRNA CTD PMID:34032870 sodium arsenite multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 sodium arsenite promotes the reaction [PRKAR2A protein binds to CAPRIN1 protein] CTD PMID:33939924 sodium fluoride increases expression ISO Prkar2a (Mus musculus) 6480464 Sodium Fluoride results in increased expression of PRKAR2A protein CTD PMID:28918527 Soman increases expression EXP 6480464 Soman results in increased expression of PRKAR2A mRNA CTD PMID:19281266 testosterone increases expression ISO PRKAR2A (Homo sapiens) 6480464 Testosterone results in increased expression of PRKAR2A mRNA CTD PMID:33359661 testosterone enanthate decreases expression EXP 6480464 testosterone enanthate results in decreased expression of PRKAR2A mRNA CTD PMID:25603467 testosterone enanthate affects expression ISO PRKAR2A (Homo sapiens) 6480464 testosterone enanthate affects the expression of PRKAR2A mRNA CTD PMID:17440010 tetrachloromethane affects expression ISO Prkar2a (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of PRKAR2A mRNA CTD PMID:17484886 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of PRKAR2A protein CTD PMID:35544339 thioacetamide increases methylation EXP 6480464 Thioacetamide results in increased methylation of PRKAR2A promoter CTD PMID:27914986 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PRKAR2A mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PRKAR2A mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of PRKAR2A mRNA CTD PMID:25729387 triclosan decreases expression ISO PRKAR2A (Homo sapiens) 6480464 Triclosan results in decreased expression of PRKAR2A mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO Prkar2a (Mus musculus) 6480464 trimellitic anhydride results in increased expression of PRKAR2A mRNA CTD PMID:19042947 triptonide increases expression ISO Prkar2a (Mus musculus) 6480464 triptonide results in increased expression of PRKAR2A mRNA CTD PMID:33045310 valproic acid increases expression ISO PRKAR2A (Homo sapiens) 6480464 Valproic Acid results in increased expression of PRKAR2A mRNA CTD PMID:23179753 and PMID:26272509 valproic acid multiple interactions ISO PRKAR2A (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKAR2A mRNA CTD PMID:27188386 zearalenone increases expression ISO PRKAR2A (Homo sapiens) 6480464 Zearalenone results in increased expression of PRKAR2A mRNA CTD PMID:19371625
